| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $33.17B | $31.80B | $29.77B |
| YoY Revenue Growth % | +4.3% | +6.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $6.07B | $5.33B | $5.03B |
| Operating Margin % | 18.3% | 16.7% | 16.9% |
| Net Income (GAAP) | $5.23B | $4.15B | $4.25B |
| EBITDA (Normalized) | $6.75B | $5.87B | $6.10B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $6.42B | $7.45B | $4.84B |
| Capital Expenditures (CapEx) | $852.0M | $683.0M | $1.34B |
| Free Cash Flow (FCF) | $5.56B | $6.77B | $3.50B |
| FCF Margin % | 16.8% | 21.3% | 11.8% |
| Return on Invested Capital (ROIC %) | 21.6% | 17.8% | 18.4% |
| Cash & Short-Term Equivalents | $8.05B | $6.66B | — |
| Total Debt (Short + Long Term) | $9.99B | $9.88B | $8.36B |
| Total Stockholders' Equity | $20.26B | $20.42B | $17.15B |